Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
100+ Artificial Intelligence Companies to Know in Healthcare | 2019
Updated
Becker’s Hospital Review
“FDNA uses artificial intelligence to analyze genetic, phenotypic information databases to detect physiological patterns that reveal disease-causing genetic variations.”
The Becker’s Hospital Review article lists leading AI innovators transforming healthcare, with a spotlight on FDNA. FDNA’s groundbreaking technology, Face2Gene, leverages AI to analyze facial features and identify genetic disorders with remarkable accuracy. This clinical decision support tool aids clinicians in diagnosing rare conditions and providing early and precise interventions. Face2Gene exemplifies the growing integration of AI in personalized medicine, significantly improving patient outcomes and clinical efficiency.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…